FoxO1 expression was distinctively upregulated in paclitaxel resistant cell line and enhanced by exposure to paclitaxel with subcellular translocation; in addition, FoxO1 overexpression was frequently observed in cancer tissue samples from chemoresistant patients (Goto and Takano, 2009). The gene discussed is FOXO1; the disease is cancer.